FDA Approves New Novartis Cancer Treatment

February 23, 2015 11:38 PM

13 0

The pharmaceutical company Novartis has been making great strides in drug development over the past several years. The company’s most recent venture is a drug called Farydak, which is aimed at treating various type of cance.

Novartis Oncology president Bruno Strigini explains “Novartis is committed to developing innovative first-in-class therapies for patients who need treatment options.” He goes on to say, “Farydak represents a new drug class in multiple myeloma, providing these patients with an important treatment app...

Read more

To category page